Quick Answer Box
- The confirmed Everlywell lawsuit is a federal privacy class action, Reedy v. Everlywell, Inc., No. 1:24-cv-02713, in the Northern District of Illinois.
- Anyone who bought a product from Everlywell.com or Natalist.com between April 4, 2019 and December 3, 2024 falls within the settlement class.
- The case resolved for $5,000,000, split between two subclasses, with final court approval already entered.
Case Snapshot
| Detail | Info |
|---|---|
| Court | U.S. District Court, Northern District of Illinois |
| Case Number | 1:24-cv-02713 |
| Presiding Judge | Andrea R. Wood |
| Filing Date | 2024, amended complaint filed September 6, 2024 |
| Status | Final approval granted April 30, 2025; distribution ongoing into 2026 |
| Settlement Fund | $5,000,000 total ($2,640,000 Sensitive Test Fund, $2,360,000 Non-Sensitive Test Fund) |
Everlywell built a business on convenience. Mail in a sample, skip the waiting room, get results on a phone screen.
That promise is now the subject of a resolved federal class action worth $5 million. Court records show the case centers on tracking technology, not the tests themselves.
Roughly two million people fall inside the settlement class. Some bought sensitive test kits, including tests for sexually transmitted infections, through Everlywell or its sister brand Natalist.
This article lays out what the court actually found, who qualifies, what the payouts look like, and where the litigation stands heading into 2026.
What Is the Everlywell Lawsuit
The Everlywell lawsuit refers to a federal class action alleging the company shared users’ private data without consent.
The case is captioned Reedy, et al. v. Everlywell, Inc., filed in the Northern District of Illinois. Plaintiffs Ashley Reedy, Joshua Cook, Melody Schoon, Jasmine Smith, and Shadari Bush brought the original claims. An amended complaint added Sedena McClain and named Baby Someday, Inc., doing business as Natalist, as a second defendant.
Both companies are subsidiaries of Everly Health, Inc., the parent brand behind Everlywell’s at-home lab testing platform.
Attorneys handling these claims point to the growing wave of pixel-tracking litigation against health and wellness brands as the backdrop for this case.
- Defendant 1: Everlywell, Inc.
- Defendant 2: Baby Someday, Inc. d/b/a Natalist
- Parent company: Everly Health, Inc.
Everlywell Class Action Lawsuit Explained
This class action alleges that website tracking tools quietly sent customer data to outside companies.
Plaintiffs claim Everlywell and Natalist installed tracking pixels built by Meta and Google on their checkout and account pages. According to the operative complaint, these tools transmitted personal information tied to what customers purchased.
The complaint frames this as a disclosure problem, not a testing-accuracy problem. That distinction matters for anyone trying to figure out if they belong in the case.
Litigation Watch: The confirmed Everlywell case is a data-sharing class action resolved for $5 million, and it is legally distinct from unverified claims elsewhere online about test-accuracy lawsuits.
Everlywell Data Privacy Allegations
The core allegation is that Everlywell and Natalist disclosed personal data to Meta and Google without proper consent.
Court filings describe the tools as “Tracking Tools,” including a Meta Pixel, embedded in the defendants’ websites. Plaintiffs say these tools captured details about test purchases, including purchases tied to sexually transmitted infection testing, and sent that data to third-party ad platforms.
That is why the settlement carves out a separate, better-funded subclass for buyers of sensitive tests. The complaint treats that category of health data as carrying higher privacy stakes than a routine retail purchase.
- Alleged tools: Meta Pixel and other website tracking technologies
- Alleged recipients: Meta Platforms, Inc. and Google LLC
- Alleged harm: disclosure of purchase and health-related information without consent
Who Qualifies for the Everlywell Settlement
You qualify if you bought a product from Everlywell.com or Natalist.com within the class period.
The class period runs from April 4, 2019 through December 3, 2024. Court documents place the total class at roughly 2 million people, split into two groups based on what they bought.
Anyone who purchased a test outside that window, or who never used either website, falls outside the settlement class.
Quick facts:
- Sensitive Test Subclass: about 660,000 members
- Non-Sensitive Test Subclass: about 1,340,000 members
- Combined class size: approximately 2,000,000 people
Everlywell Lawsuit Eligibility Requirements
Eligibility depends on which category of product a person bought, not on whether their test results were accurate.
The Sensitive Test Subclass covers buyers of tests the settlement defines as sensitive, including STI test kits. The Non-Sensitive Test Subclass covers everyone else who bought a covered product or service on either site.
Attorneys handling these claims point to purchase records and confirmation emails as the strongest proof of subclass membership.
| Subclass | What Qualifies |
|---|---|
| Sensitive Test | STI test kits and similarly categorized purchases |
| Non-Sensitive Test | Other Everlywell or Natalist test kits and products |
Everlywell Settlement Payout Amounts
Payouts are pro rata, meaning the final dollar figure depends on how many people filed valid claims.
Class counsel and the settlement administrator do not guarantee a fixed dollar amount per person. Instead, each subclass fund is divided among everyone who filed a valid, timely claim, after fees and costs are deducted.
Members of the Sensitive Test Subclass are positioned to receive a larger individual share, since their fund is smaller relative to their subclass size than the non-sensitive fund is to its own.
Bold callout: Because payouts are pro rata, no website can promise a specific check amount before the administrator finishes processing claims.
Everlywell Lawsuit Settlement Fund Breakdown
The total settlement fund is $5,000,000, divided into two separate pools by subclass.
Court filings confirm $2,640,000 was allocated to the Sensitive Test Settlement Fund. The remaining $2,360,000 was allocated to the Non-Sensitive Test Settlement Fund. Both funds cover claimant payments, notice costs, attorney’s fees, and service awards to the named plaintiffs.
| Fund | Amount |
|---|---|
| Sensitive Test Settlement Fund | $2,640,000 |
| Non-Sensitive Test Settlement Fund | $2,360,000 |
| Total Settlement | $5,000,000 |
Litigation Watch: Every dollar figure tied to this case traces back to the settlement agreement filed in Reedy v. Everlywell, not to estimates.
Everlywell Lawsuit Timeline
The case moved from filing to final court approval in roughly a year and a half.
An amended complaint naming Natalist and plaintiff Sedena McClain was filed on September 6, 2024. The court granted preliminary approval of the settlement in December 2024. Final approval followed on April 30, 2025, after a hearing the day before.
| Date | Event |
|---|---|
| September 6, 2024 | Amended complaint filed, adding Natalist as a defendant |
| December 2024 | Preliminary approval of settlement granted |
| March 19, 2025 | Claim filing deadline |
| April 29, 2025 | Final approval hearing held in Chicago |
| April 30, 2025 | Final approval order entered by Judge Wood |
Everlywell Lawsuit Court and Judge
The case is assigned to Judge Andrea R. Wood in the Northern District of Illinois.
Judge Wood presided over both the preliminary and final approval stages. The final approval hearing took place at the Everett M. Dirksen U.S. Courthouse, 219 South Dearborn Street, Chicago, in Courtroom 2141.
Attorneys handling these claims point to the Northern District of Illinois as an increasingly common venue for pixel-tracking privacy cases against consumer health brands.
- Court: U.S. District Court for the Northern District of Illinois
- Judge: Andrea R. Wood
- Courthouse: Everett M. Dirksen U.S. Courthouse, Chicago
Everlywell Lawsuit Filing Deadline
The deadline to submit a claim form was March 19, 2025, and that window has closed.
Class members also had until that date to opt out of the settlement or file a formal objection ahead of the final approval hearing. Anyone who missed that deadline generally cannot submit a late claim into this specific fund.
Bold callout: The claim deadline for this settlement has passed; the current 2026 focus is on payment distribution, not new filings.
How to File an Everlywell Lawsuit Claim
Claims for this settlement had to be filed online or by mail using a Class Member ID from the official notice.
Sensitive Test Subclass members and Non-Sensitive Test Subclass members used separate claim forms. Mailed forms had to be postmarked by the March 2025 deadline, and online submissions had to be completed by the same date.
- Step 1: Locate the Class Member ID from the settlement notice
- Step 2: Choose the correct claim form for your subclass
- Step 3: Submit online or mail to the settlement administrator by the deadline
Everlywell Lawsuit Settlement Administrator
Kroll Settlement Administration LLC handles claims processing, notices, and payment distribution for this case.
The administrator operates the official settlement website and a dedicated case phone line for class members with questions. All exclusion requests and objections were required to be mailed directly to Kroll’s processing address in New York.
Quick facts:
- Administrator: Kroll Settlement Administration LLC
- Case reference: Case #83136
- Mailing address: PO Box 225391, New York, NY 10150-5391
Everlywell Lawsuit Appeals and Final Approval
Final approval was granted on April 30, 2025, but payments still depend on the appeals window closing.
Under standard class action procedure, settlement funds are not distributed until any appeal period expires. As of the most recent public case updates, the settlement had cleared final approval and was moving toward payment distribution.
Attorneys handling these claims point to this appeals buffer as the reason payout timing can lag months behind a final approval order, even in an uncontested settlement.
Litigation Watch: Final approval is not the same as payment. Class members should expect distribution to follow the appeals period, not the approval date itself.
Everlywell Lawsuit by State
This is a nationwide federal class action, so eligibility does not depend on which state a claimant lives in.
Because the case proceeded in federal court under Illinois federal jurisdiction, class membership is defined by purchase history, not residency. A person in Texas and a person in Illinois qualify under identical terms if they bought a covered product in the class period.
State law still matters for anyone considering a separate, individual claim outside this settlement, since consumer protection statutes and filing deadlines vary by state.
| Factor | Nationwide Rule |
|---|---|
| Residency requirement | None |
| Governing venue | Northern District of Illinois |
| Basis for eligibility | Purchase history, not home state |
Everlywell Lawsuit Law Firms Involved
Plaintiffs in this case were represented by attorneys from Almeida Law Group and Siri & Glimstad LLP.
Court records list attorneys Mason Barney and David DiSabato of Siri & Glimstad LLP among plaintiffs’ counsel. Almeida Law Group also represented the settlement class through final approval.
- Plaintiffs’ counsel: Almeida Law Group
- Plaintiffs’ counsel: Siri & Glimstad LLP (Mason Barney, David DiSabato)
- Defendants: Everlywell, Inc. and Baby Someday, Inc. d/b/a Natalist
Everlywell Consumer Complaints Beyond the Settlement
Separate from the privacy settlement, some consumers have raised concerns about test result reliability in reviews and individual complaints.
These complaints are not the same legal matter as Reedy v. Everlywell. As of mid-2026, no confirmed, court-verified class action or federal settlement tied specifically to test accuracy claims had been publicly documented through primary court records.
Readers should treat generalized claims about a separate “test accuracy lawsuit” with caution until they can point to an actual docket number or agency order.
Bold callout: The only Everlywell case with a confirmed docket number, judge, and settlement fund as of 2026 is the pixel-tracking privacy action.
When to Contact an Attorney About Everlywell
Contact an attorney if you believe your data was misused in a way this settlement does not cover, or if you have an individual injury claim.
The pixel-tracking settlement resolves the specific claims described in Reedy v. Everlywell. It does not cover unrelated disputes, such as a claim that a specific test result caused a documented medical decision or financial loss.
A privacy litigation or consumer protection attorney can evaluate whether facts outside this settlement support a separate claim.
- Situations that may warrant a consultation: data misuse not covered by this settlement, disputes over a specific denied or delayed refund, state-specific consumer protection claims
- Situations already resolved by this case: pixel-based data sharing claims within the April 2019 to December 2024 class period
Frequently Asked Questions
Is there an active Everlywell lawsuit in 2026?
The confirmed federal case, Reedy v. Everlywell, reached final settlement approval in April 2025.
As of 2026, the matter is in the payment distribution phase rather than active litigation.
Who qualifies for the Everlywell settlement?
Anyone who bought a product from Everlywell.com or Natalist.com between April 4, 2019, and December 3, 2024, qualifies.
Eligibility depends on purchase history, not on the accuracy of any test result.
How much money can I get from the Everlywell settlement?
Payments are pro rata, so the exact amount depends on the total number of valid claims filed.
The Sensitive Test Fund holds $2,640,000, and the Non-Sensitive Test Fund holds $2,360,000.
What is the deadline to file an Everlywell claim?
The claim filing deadline was March 19, 2025, and it has already passed.
Anyone who missed that date generally cannot submit a new claim into this specific settlement.
Which court is handling the Everlywell lawsuit?
The case is in the U.S. District Court for the Northern District of Illinois.
Judge Andrea R. Wood presided over both preliminary and final settlement approval.
Can I still sue Everlywell if I missed the claim deadline?
Missing the claim deadline in this settlement does not automatically bar every possible legal option.
An attorney can review whether a separate, individual claim outside this class action may still apply.
Everlywell’s pixel-tracking settlement shows how quickly a privacy case can move from filing to final approval when the facts are well documented. The $5 million fund is confirmed, the judge is named, and the docket number is public.
Anyone who bought a covered product should track the distribution timeline through the settlement administrator. Anyone with a separate, unresolved dispute involving Everlywell should speak with an attorney who handles data privacy or consumer protection claims before assuming this settlement covers it.
